A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease

Gastroenterology

Volumn 123, Issue 1, 2002, Pages 163-172

  Zolotarevsky, Yevgeny ^a   Hecht, Gail ^b   Koutsouris, Athanasia ^b   Gonzalez, Deborah E ^c   Quan, Cliff ^c   Tom, Jeffrey ^c   Mrsny, Randall J ^c   Turner, Jerrold R ^a,d  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c GENENTECH INC   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MYOSIN ADENOSINE TRIPHOSPHATASE; MYOSIN LIGHT CHAIN KINASE; MYOSIN LIGHT CHAIN KINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

APICAL MEMBRANE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOSKELETON; ELECTROPHYSIOLOGY; ENTEROPATHY; ENZYME ASSAY; HUMAN; HUMAN CELL; INTESTINE MUCOSA; MEMBRANE PERMEABILITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TIGHT JUNCTION;

EID: 0036305854     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.34235     Document Type: Article

References (41)

1. Is small intestinal permeability really increased in relatives of patients with Crohn’s disease?
2. Intestinal permeability in patients with Crohn’s disease and their first degree relatives
3. Increased intestinal permeability precedes the onset of Crohn’s disease in a subject with familial risk
4. Abnormal intestinal permeability predicts relapse in inactive Crohn disease
5. Intestinal permeability test as a predictor of clinical course in Crohn’s disease
6. Intestinal permeability and the prediction of relapse in Crohn’s disease
7. Enteropathogenic Escherichia coli adherence to intestinal epithelial monolayers diminishes barrier function
8. Signal transduction pathways involved in enterohemorrhagic Escherichia coli-induced alterations in T84 epithelial permeability
9. Vibrio cholerae-induced cellular responses of polarized T84 intestinal epithelial cells are dependent on production of cholera toxin and the RTX toxin
10. Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model
11. Apically exposed, tight junction-associated beta1-integrins allow binding and YopE-mediated perturbation of epithelial barriers by wild-type Yersinia bacteria
12. Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers
13. Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins
14. Ethanol modulation of intestinal epithelial tight junction barrier
15. Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation
16. Protein kinase C-dependent regulation of transepithelial resistance: The roles of myosin light chain and myosin light chain kinase
17. ’Putting the squeeze’ on the tight junction: Understanding cytoskeletal regulation
18. Enteropathogenic Escherichia coli-induced myosin light chain phosphorylation alters intestinal epithelial permeability
19. Identification of novel classes of protein kinase inhibitors using combinatorial peptide chemistry based on functional genomics knowledge
20. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers
21. Tumor necrosis factor-alpha (TNF-alpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6
22. Tumour necrosis factor-alpha induces morphological and functional alterations of intestinal HT29 cl.19A cell monolayers
23. Synergistic effects of interferon gamma and tumour necrosis factor alpha on T84 cell function
24. Autocrine regulation of epithelial permeability by hypoxia: Role for polarized release of tumor necrosis factor alpha
25. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn’s ileocolitis
26. Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function
27. Expression of a novel high molecular-weight myosin light chain kinase in endothelium
28. Proteolysis of smooth muscle myosin light chain kinase. Formation of inactive and calmodulin-independent fragments
29. In vivo protein transduction: Delivery of a biologically active protein into the mouse
30. Expression of the catalytic domain of myosin light chain kinase increases paracellular permeability
31. Tight junctions and the molecular basis for regulation of paracellular permeability
32. Regulation of the movement of solutes across tight junctions
33. +-glucose cotransport
34. Unique sequence of a high molecular weight myosin light chain kinase is involved in interaction with actin cytoskeleton
35. Regulation of tight junctions by extracellular stimuli: Nutrients, cytokines, and immune cells
36. Environmental stress-induced gastrointestinal permeability is mediated by endogenous glucocorticoids in the rat
37. Differential effect of MLC kinase in TNF-alpha-induced endothelial cell apoptosis and barrier dysfunction
38. Myosin II light chain phosphorylation regulates membrane localization and apoptotic signaling of tumor necrosis factor receptor-1
39. Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin
40. Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma
41. Enteropathogenic Escherichia coli dephosphorylates and dissociates occludin from intestinal epithelial tight junctions